D'Alessandro Danilo 4

What Happened
Danilo D'Alessandro, Chief Financial Officer of ClearPoint Neuro, had 32,627 restricted stock units (RSUs) settle into common shares on 2026-03-12. To satisfy tax withholding obligations, 16,601 of those shares were delivered back to the company at a reported withholding value of $11.53 per share, totaling $191,410. The net shares delivered to D'Alessandro were 16,026 (32,627 vested minus 16,601 withheld). This was an award/vesting event, not an open-market sale or purchase.

Key Details

• Transaction date: 2026-03-12; Form 4 filed: 2026-03-16 (filed 4 days after the transaction; may be late under the 2-business-day Form 4 rule).
• Vesting/settlement: 32,627 RSUs converted to common stock (transaction code M).
• Tax withholding: 16,601 shares withheld and delivered to ClearPoint (transaction code F) at $11.53/share = $191,410.
• Net shares received by insider: 16,026 shares.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 confirms these were RSUs settled on their scheduled vesting date; F2 confirms the withheld shares satisfied tax obligations.

Context
This was a routine RSU vesting and net-share settlement (shares withheld for taxes), not an open-market sale or purchase. For retail investors, awards/vesting show compensation realization but do not necessarily indicate the insider’s market view. The tax-withholding reduces the number of shares actually received by the insider.